Journal of Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

Vikrant Rai

Department of Biomedicine, Western University of Health Sciences, CA 91766, USA

  • Mini Review   
    Biomarkers for Esophageal Cancer Early Detection, Prognosis and Therapy
    Author(s): Vikrant Rai*

    Esophageal cancer is the deadliest cancer in the world, with a 92% annual mortality rate per incidence. The two major types of ECs are esophageal squamous cell carcinoma and esophageal adenocarcinoma, with EAC having one of the worst prognoses in oncology. Limited screening techniques and a lack of molecular analysis of diseased tissues have resulted in late-stage presentation and extremely short survival times. The five-year survival rate of EC is less than 20%. Thus, early detection of EC may increase survival and improve clinical outcomes. Cellular and molecular biomarkers are used in diagnosis. However, this is an invasive method that does not produce a molecular profile of the diseased compartment. To reduce the invasiveness of diagnostic procedures, researchers are proposing non-invasive biomarkers for early diagnosis and point-of-care screening options... Read More»
    DOI: 10.37421/2155-9929.2023.14.566

    Abstract HTML PDF

Google Scholar citation report
Citations: 2054

Journal of Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Journal of Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

arrow_upward arrow_upward